降血糖药

我院1998~2002年口服降血糖药的用药分析

Analysis of Oral Hypoglycemic Agents Used During 1998 - 2002 in Our Hospital

口服降血糖药的研究进展与临床应用

Research Progress and Clinical of Oral Hypoglycemic Agents

该医院25种降血糖药的金额序号与DDDs序号之比在0.17-5.3之间；

The ratio of the order of cost to the one of DDDs about 25 hypoglycemic drugs was from 0.17 to 5.3 ;

某三甲医院降血糖药使用分析及趋势研究结论：CSII治疗能够缩短达到理想血糖控制所需时间，有效降低餐后2小时血糖，减少胰岛素用量，减少低血糖的发生。

An Analysis of the Trend and Consumption of Hypoglycemic Drugs in a 3A Grade Hospital from 2001 to 2003 Conclusions : CSII could shorten the duration of insulin treatment , lower 2-hour postprandial blood sugar ( PBS2 ) and reduce insulin dosage , and hypoglycemic episodes .

我院2005&2007年降血糖药使用情况分析

Analysis of Hypoglycemic Drugs Use in Our Hospital from 2005 to 2007

结论我院降血糖药应用基本合理。

CONCLUSION The use of hypoglycemic drugs is approximate rational .

目的为临床合理应用口服降血糖药提供信息。

OBJECTIVE To provide the information for rational administer of oral hypoglycemic drugs .

两种降血糖药的元素含量测定及其临床意义

Determination of Elements in Blood - sugar Decreasing Medicine and Its Clinical Significance

目的：了解我院口服降血糖药的使用情况。

Objective : To evaluate the oral hypoglycemic agents used in our hospital .

降血糖药的药物利用研究及经济学分析

Utilization study and economic analysis of hypoglycemic drugs

结论：口服降血糖药的使用呈增长趋势。

Conclusion : It presents the increasing trend in the use of o-ral hypoglycemic agents .

2003年~2005年我院降血糖药临床应用分析

Analysis of the Clinical Application of Hypoglycemic Agents in Our Hospital During 2003 ~ 2005

结果与结论：提出了几点合理应用口服降血糖药的建议。

RESULTS CONCLUSION : Some suggestions for rational use of oral hypoglycemic agents were made .

结论：降血糖药是当前具有发展前途的一类药物。

Conclusion : The antidiabetic agents is a kind of common drugs with a bright future of development .

1999年～2001年我院降血糖药用药状况分析

Analysis of the Situation and Trend of Hypoglycemic Agents in Renji Hospital During the Period 1999 ~ 2001

目的：了解某三甲医院降血糖药的使用情况和发展趋势。

Objective : To investigate the use of hypoglycemic drugs and its developing trend in a 3A grade hospital .

糖尿病病人、口服降血糖药品种和数量以及零售金额均有增加趋势。

Diabetes patients , variety and amount of the mouth-taking blood sugar declining medicines take on an increasing trend .

方法：对我院1998~2002年口服降血糖药的应用频率、消耗金额进行统计分析。

Method : The frequency and sum of money in consumption of oral hypoglycemic agents during 1998-2002 were analysed .

临床用药量动态分析表明格列齐特、格列喹酮、格列本脲（优降糖）为武汉协和医院主要的口服降血糖药。

The comparative analysis revealed that gliclazide , glurenorm and glibenclamide were the main oral hypoglycemic agents in our hospital .

格列齐特是第二代磺酰脲类口服降血糖药，用于治疗非胰岛素依赖型糖尿病（Ⅱ型糖尿病）。

Gliclazide , a second generation sulfonylurea hypoglycaemic agent , is used in the treatment of Type II diabetes mellitus .

盐酸二甲双胍是一种降血糖药，具有提高2型糖尿病患者的血糖耐受性，降低基础和餐后血糖的作用。

Metformin is an antihyperglycemic agent which improves glucose tolerance in patients with type 2 diabetes , lowering both basal and postprandial plasma glucose .

目的观察预混门冬氨酸胰岛素30/70（降血糖药）对2型糖尿病的疗效与安全性。

Objective To investigate the efficacy and safety of insulin aspart 30 / 70 in the treatment of type 2 diabetes mellitus ( T2DM ) .

方法：介绍口服降血糖药的研究进展，对几种新型口服降血糖药进行临床应用评价。

METHODS : To give an account of research progress in oral hypoglycemic agents and to give the clinical evaluation on newly developed oral hypoglycemic agents .

近年来Ⅰ型降血糖药和Ⅱ型降血糖药在治疗糖尿病方面不断取得新进展，但仍无法阻止糖尿病的高发率。

Recently , the high morbility of diabetes is still present though type 1 and type 2 hypoglycemic agents have achieved continuously progress in treatment of diabetes .

结果我院降血糖药品种、数量及销售金额逐年增长，其中以口服降血糖药为主导用药。

RESULTS The varieties quantities and sales volumes of hypoglycemic drugs increased year by year , while oral hypoglycemic drugs were the leading drugs in our hospital .

由于胰岛素和口服化学合成药存在副作用，使得天然降血糖药日益受到糖尿病患者的青睐。

There is an increasing demand of patients for use of the natural products with anti-diabetic activity due to the side effects associated with the use of insulin and oral hypoglycemic agents .

目的研究壳聚糖和壳聚糖EDTA接合物（CEC）双层包覆胰岛素脂质体的性质、降血糖作用和药代动力学。

Aim To evaluate the characteristics , the hypoglycemic efficacy and the pharmacokinetics of the insulin-liposomes double-coated by chitosan ( CH ) and chitosan-EDTA conjugates ( CEC ) .

玉泉丸对二甲双胍降血糖作用及药动学影响研究

Study on the Effects of Yuquan Pill on the Hypoglycemic Activity and Pharmacokinetics of Metformin

方法采用原位肠袢法，设计肠道冲洗实验，测定胰岛素肠道吸收后的降血糖效应和血药浓度。

Methods The intestinal absorption of insulin was evaluated by its hypoglycemic effect and serum insulin level using an in situ loop method with the washing treatment .